Mawer Investment Management Ltd. Has $37.44 Million Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Mawer Investment Management Ltd. trimmed its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 7.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 583,500 shares of the company’s stock after selling 44,939 shares during the quarter. Mawer Investment Management Ltd.’s holdings in Ryan Specialty were worth $37,437,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Rakuten Securities Inc. acquired a new stake in shares of Ryan Specialty in the fourth quarter valued at approximately $27,000. Principal Securities Inc. lifted its holdings in shares of Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company’s stock worth $43,000 after acquiring an additional 415 shares during the period. Quarry LP boosted its position in shares of Ryan Specialty by 109.3% during the 3rd quarter. Quarry LP now owns 808 shares of the company’s stock worth $54,000 after acquiring an additional 422 shares in the last quarter. Harvest Fund Management Co. Ltd bought a new position in Ryan Specialty in the fourth quarter valued at approximately $54,000. Finally, R Squared Ltd bought a new stake in Ryan Specialty during the fourth quarter worth $92,000. Institutional investors own 84.82% of the company’s stock.

Insiders Place Their Bets

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 10,485 shares of the stock in a transaction that occurred on Thursday, January 23rd. The shares were sold at an average price of $65.12, for a total value of $682,783.20. Following the sale, the director now directly owns 11,109 shares in the company, valued at $723,418.08. This represents a 48.56 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 241,360 shares of company stock valued at $16,006,428. Corporate insiders own 11.10% of the company’s stock.

Ryan Specialty Stock Performance

Shares of RYAN stock opened at $72.98 on Friday. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a 52 week low of $48.48 and a 52 week high of $75.97. The firm has a 50 day moving average of $68.74 and a 200-day moving average of $68.28. The company has a market cap of $19.11 billion, a price-to-earnings ratio of 105.77, a price-to-earnings-growth ratio of 1.19 and a beta of 0.71.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). The company had revenue of $663.53 million for the quarter, compared to the consensus estimate of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. On average, equities analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were paid a dividend of $0.12 per share. The ex-dividend date was Tuesday, March 4th. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a yield of 0.66%. Ryan Specialty’s dividend payout ratio (DPR) is 69.57%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on RYAN shares. Royal Bank of Canada decreased their price target on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a research note on Friday, February 21st. Keefe, Bruyette & Woods lowered their target price on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a research note on Friday, February 21st. Morgan Stanley started coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target on the stock. Wells Fargo & Company increased their price objective on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a research note on Friday, February 21st. Finally, UBS Group increased their price target on Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. One analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $75.27.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.